News
Pharmaceutical Outsourcing Features Amanda Parsons: Best Practices for Data Collection in Decentralized Clinical Trials
Read More
Recent News at Rho
Advancing science, earning recognition
News
First Wave BioPharma Engages Rho to Manage Phase 2 Clinical Trial of Enhanced Adrulipase Formulation
Read More
News
FreshAAIR Magazine: Black and Hispanic Children Are at a Higher Risk of Developing Asthma Across All Neighborhoods (and Income Levels)
Read More
News
Triangle Business Journal’s People on the Move – Marc Pipas
Read More
News
2022 Best Places to Work Awards: Rho (Extra large companies)
Read More
News
Triangle Business Journal’s People on the Move: Peter Schmidt, SVP, Global Partnerships at Rho
Read More
News
Bio IT World: Rho Named A 2022 Health Care Leadership Award Winner by Triangle Business Journal
Read More
News
Triangle Business Journal: RTP company lands $49M contract on heels of banner year
Read More
News
yahoo! Entertainment: Rho Awarded NIH-NIAID Contract to Support Clinical Research in Autoimmune Diseases
Read More
News
Accesswire: Rho Awarded NIH-NIAID Contract to Support Clinical Research in Autoimmune Diseases
Read More
Breaking New Ground in Food Allergy Treatment: Xolair Approval
Nicole Rogers, Associate Director, Project Management, shares a powerful perspective on what it means to be part of the OUtMATCH study, a groundbreaking food allergy study that supported the approval of Xolair.
Clinical Trial Enrollment Caps: What They Are and When to Use Them
What’s the secret to optimizing your clinical trial? It could be understanding enrollment caps and knowing exactly when to set them.
Breathing New Insights: Exploring the Dynamic Connection Between Lung Function, Allergy and Wheezing in Urban Children
Cindy Visness, PhD, Rho’s Principal Research Scientist, worked with investigators on the NIAID-funded Urban Environment and Childhood Asthma (URECA) study to dissect the complex web of factors influencing respiratory health in city-living children in the article, “Relationships between lung function, allergy, and wheezing in urban children” available in The Journal of Allergy and Clinical Immunology April edition.
Tips to Rescue a Clinical Trial Before It’s Too Late
Sometimes relationships can continue even when things aren’t working out. However, when it comes to the partnership between a sponsor and its contract research organization (CRO), there isn’t any time to waste. Failing to address issues quickly during a clinical trial can cause issues.
Unlocking sleep’s role in PTSD
Ben Vaughn, Rho’s Chief Strategist, Biostatistics & Protocol Design, supports Tonix Pharmaceutical’s analyses of how sleep disturbances impact posttraumatic stress disorder (PTSD). Their research sheds light on a novel treatment, TNX-102 SL, which targets sleep quality and emotional memory processing.
Understanding GDPR Compliance in Clinical Trials
Dive into the complexities of GDPR compliance in clinical trials in Contract Pharma’s article, Understanding GDPR Compliance in Clinical Trials, an interview with Laura Gatavs, Head of Legal Department for Rho EU. Explore the nuances of when and where GDPR applies, grasp the basics of compliance – both at company compliance level and when negotiating clinical trial agreements – and uncover essential takeaways and best practices for clinical trial sponsors.
Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the FDA for Approval of Tonmya™ for the Management of Fibromyalgia
Rho is thrilled to announce our unwavering support for Tonix Pharmaceuticals as they prepare to submit their New Drug Application (NDA). Serving as a dedicated partner to Tonix, we are committed to providing the necessary resources and expertise to support the next steps toward regulatory approval of Tonmya™ for the management of fibromyalgia. Our collaboration underscores our shared dedication to advancing healthcare solutions that improve patient outcomes and enhance the quality of life. We are grateful to be a part of such an exciting partnership as we continue to champion breakthrough advancements in drug development.